1. The Genomics Revolution: Will this Mean a Resurgence of Customized Prescriptions?

   • A. Ruano-Ravina
   • A. Figueiras
   • J. M. Barros-Dios

   OriginalPaper 31 December 2002 Pages: 725 - 726

2. The Cultural Framework for the Ethical Review of Clinical Research in Latin America

   • Nora Cavazos
   • D. Forster
   • A. J. Bowen

   OriginalPaper 31 December 2002 Pages: 727 - 737

3. Placebo Controlled Clinical Trials are as Ethical as Active Controlled Trials Even if Effective Therapies Exist

   • Yeong-Liang Lin
   • Herng-Der Chern
   • Mong-Ling Chu

   OriginalPaper 31 December 2002 Pages: 739 - 741

4. The Impact of the Implementation of the International Conference on Harmonisation Essential Documents on Investigator Sites

   • Luis Peña Icart
   • Olga J. Torres Gemeil
   • Helene Sancho-Garnier

   OriginalPaper 31 December 2002 Pages: 743 - 750

5. Associating Genes to Drug Response

   • David A. Katz

   OriginalPaper 31 December 2002 Pages: 751 - 761

6. Sponsors’ Experiences with Site Management Organizations in Japan

   • Koichi Miyazaki
   • Hironobu Saito

   OriginalPaper 31 December 2002 Pages: 763 - 768

7. Establishing Shelf Life, Expiry Limits, and Release Limits

   • John R. Murphy
   • Jeffrey D. Hofer

   OriginalPaper 31 December 2002 Pages: 769 - 781

8. Design and Evaluation of the Pharmacoinformatics Course at a Pharmacy School in Malaysia

   • Ab Fatah Ab Rahman
   • Mohamed Izham Mohamed Ibrahim
   • Rahmat Awang

   OriginalPaper 31 December 2002 Pages: 783 - 789

9. Technological Innovations in Professional Services

   • Erik W. Klein
   • Kristen W. Mosdell
   • Michael L. Kleinberg

   OriginalPaper 31 December 2002 Pages: 791 - 805

10. Naming, Classification, And Trademark Selection: Implications For Market Success Of Pharmaceutical Products

    • Florian Gantner
    • Christian Schweiger
    • Michael Schlander

    OriginalPaper 31 December 2002 Pages: 807 - 824

11. Managing Medical Information Effectively Facilitates the Quality and Time to Delivering the Final Product

    • Ivor Cowlrick
    • Jeroen Dumon
    • Manfred Bauleser

    OriginalPaper 31 December 2002 Pages: 825 - 829

12. The Attitude of Pharmaceutical Industry Research Scientists to Browsing and Publishing on Internet Preprint and E-Print Servers

    • Giovanna F. Miranda
    • Jeanette Ginestet

    OriginalPaper 31 December 2002 Pages: 831 - 837

13. Building a Computerized Herbal Substance Register for Implementation and Use in the World Health Organisation International Drug Monitoring Programme

    • Helena Fucik
    • Anders Backlund
    • Mohamed Farah

    OriginalPaper 31 December 2002 Pages: 839 - 854

14. Dose Spacing in Early Dose Response Clinical Trial Designs

    • Anthony Hamlett
    • Naitee Ting
    • Jeffrey S. Finman

    OriginalPaper 31 December 2002 Pages: 855 - 864

15. An Investigation of the Traditional Algorithm-Based Designs for Phase 1 Cancer Clinical Trials

    • Seung-Ho Kang
    • Chul W. Ahn

    OriginalPaper 31 December 2002 Pages: 865 - 873

16. Is It Possible to Claim Efficacy if One of Two Trials is Significant While the other Just Shows a Trend?

    • Gerd Rosenkranz

    OriginalPaper 31 December 2002 Pages: 875 - 879

17. Nonparametric Identification of the Minimum Effective Dose

    • Markus Neuhauser

    OriginalPaper 31 December 2002 Pages: 881 - 888

18. The Regulation of Dietary Supplements in the Republic of Armenia

    • Emil Gabrielyan
    • Elmira Amroyan
    • Annet Zakaryan

    OriginalPaper 31 December 2002 Pages: 889 - 897

19. Review 2001: The Future of European Pharmaceutical Legislation

    • Louise Lamb
    • Paolo M. Biffignandi

    ReviewPaper 31 December 2002 Pages: 899 - 907

20. New Directions in Pharmacoeconomic Research: The Next Step

    • Hirsch S. Ruchlin
    • Erik J. Dasbach
    • Joseph F. Heyse

    OriginalPaper 31 December 2002 Pages: 909 - 917

21. Outcomes Research Support of Potential Blockbuster Drugs

    • Pablo Lapuerta
    • Roland Chen

    OriginalPaper 31 December 2002 Pages: 919 - 926

22. Data Normalization Techniques and Autocoding Algorithms for The Medical Dictionary for Regulatory Activities (MedDRA)

    • Mike Don Tucker

    OriginalPaper 31 December 2002 Pages: 927 - 933